Dow Up0.59% Nasdaq Up0.75%

Revance Therapeutics, Inc. (RVNC)

-NasdaqGM
20.89 Up 0.41(2.00%) Sep 16, 4:00PM EDT
Analyst EstimatesGet Analyst Estimates for:
Earnings EstCurrent Qtr.
Sep 14
Next Qtr.
Dec 14
Current Year
Dec 14
Next Year
Dec 15
Avg. Estimate-0.70-0.74-3.14-3.42
No. of Analysts2.002.002.003.00
Low Estimate-0.74-0.74-3.25-3.65
High Estimate-0.66-0.73-3.02-3.27
Year Ago EPSN/AN/A1.05-3.14
Revenue EstCurrent Qtr.
Sep 14
Next Qtr.
Dec 14
Current Year
Dec 14
Next Year
Dec 15
Avg. Estimate100.00K100.00K170.00K170.00K
No. of Analysts1133
Low Estimate100.00K100.00KNaNNaN
High Estimate100.00K100.00K500.00K500.00K
Year Ago SalesNaNNaN617.00K170.00K
Sales Growth (year/est)N/AN/A-72.40%0.00%
Earnings HistoryMar 14Jun 14
EPS EstN/AN/A-0.87-0.68
EPS ActualN/AN/A-1.08-0.69
DifferenceN/AN/A-0.21-0.01
Surprise %N/AN/A-24.10%-1.50%
EPS TrendsCurrent Qtr.
Sep 14
Next Qtr.
Dec 14
Current Year
Dec 14
Next Year
Dec 15
Current Estimate-0.70-0.74-3.14-3.42
7 Days Ago-0.70-0.74-3.14-3.42
30 Days Ago-0.70-0.74-3.14-3.42
60 Days Ago-0.70-0.72-2.84-3.42
90 Days Ago-0.82-0.87-3.28-3.34
EPS RevisionsCurrent Qtr.
Sep 14
Next Qtr.
Dec 14
Current Year
Dec 14
Next Year
Dec 15
Up Last 7 Days0000
Up Last 30 Days0000
Down Last 30 Days0000
Down Last 90 DaysN/AN/AN/AN/A
Growth EstRVNCIndustrySectorS&P 500
Current Qtr.N/AN/A-76.30%13.50%
Next Qtr.N/AN/A-64.90%23.60%
This Year-399.00%N/A45.00%7.60%
Next Year-8.90%N/A34.80%13.00%
Past 5 Years (per annum)0.00%N/AN/AN/A
Next 5 Years (per annum)N/A21.77%15.53%10.15%
Price/Earnings (avg. for comparison categories)-6.95-0.103.965.68
PEG Ratio (avg. for comparison categories)N/A29.757.890.90
Currency in USD.